Clinical efficacy of integrated traditional Chinese and western medicine in the treatment of oligoasthenospermia in male infertility of kidney-yang deficiency type

Abstract

This study examines the clinically comprehensive effects of Wuzi Shenqi Decoction, an acupoint application that combines traditional Chinese medicine with western medicine on male infertility with oligoasthenospermia of kidney-yang deficiency type. A total of 184 male infertiles with oligoasthenospermia who came to our hospital from April 2022 to June 2023 were randomly assigned to a study group (n = 92) and an experimental group (n = 92). The experimental group was treated with L-carnitine oral solution, while the study group was treated with Wuzi Shenqi Decoction combined with acupoint application based on the experimental group. Before and after treatment, clinical efficacy, semen parameters (semen volume, sperm density, sperm survival rate, sperm motility), sexual hormone parameters (follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T), prolactin (PRL), estradiol), and TCM (Traditional Chinese Medicine) syndrome scores were observed and compared between both groups. Before treatment, there was no significant difference in semen parameter index, sexual hormone index and TCM syndrome score between both groups (p > 0.05); after treatment, the semen parameter index and sexual hormone index in both groups were higher than before treatment, and the TCM syndrome score was diminished with a significant difference (p < 0.05). The overall response rate of the study group was 92.39%, which was significantly higher than that of the experimental group (72.83%)(p < 0.05). For male infertility patients with oligoasthenospermia of kidney-yang deficiency type, the use of Wuzi Shenqi Decoction combined with traditional Chinese medicine acupoint application plus L-carnitine oral solution can effectively improve the clinical symptoms of patients, improve semen quality, regulate sex hormone levels, which is worthy of clinical application.

Wuzi Shenqi Decoction; Acupoint application; Kidney-yang deficiency type; Oligoasthenospermia

[1] Dougherty GW, Mizuno K, Nöthe-Menchen T, Ikawa Y, Boldt K, Ta-Shma A, et al. CFAP45 deficiency causes situs abnormalities and asthenospermia by disrupting an axonemal adenine nucleotide homeostasis module. Nature Communications. 2020; 11: 5520.

[2] Jiao J, Xu P, Wang X, Xing Z, Dong S, Li G, et al. Enterotypes in asthenospermia patients with obesity. Scientific Reports. 2022; 12: 16993.

[3] Liang G, Wang Q, Zhang G, Li Z, Wang Q. Differentially expressed miRNAs and potential therapeutic targets for asthenospermia. Andrologia. 2022; 54: e14265.

[4] Zhao Y, Yang J, Lu D, Zhu Y, Liao K, Tian Y, et al. The loss-function of KNL1 causes oligospermia and asthenospermia in mice by affecting the assembly and separation of the spindle through flow cytometry and immunofluorescence. Sensors. 2023; 23: 2571.

[5] Zhou S, Wu H, Zhang J, He X, Liu S, Zhou P, et al. Bi-allelic variants in human TCTE1/DRC5 cause asthenospermia and male infertility. European Journal of Human Genetics. 2022; 30: 721–729.

[6] Zhimin C, Mingyue AO, Yujiao L, Lingying YU, Zhuo Y, Lin HU, et al. Wuzi Yanzong prescription from traditional Chinese medicine for male infertility: a narrative review. Journal of Traditional Chinese Medicine. 2023; 43: 416–428.

[7] Chen WQ, Ding CF, Yu J, Wang CY, Wan LY, Hu HM, et al. Wuzi Yanzong pill-based on network pharmacology and in vivo evidence-protects against spermatogenesis disorder via the regulation of the apoptosis pathway. Frontiers in Pharmacology. 2020; 11: 592827.

[8] Pan T, Xiao Q, Fan H, Xu L, Qin S, Yang L, et al. Wuzi Yanzong pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation. Metabolic Brain Disease. 2023; 38: 2211–2222.

[9] Xu Y, Li Y, Hu S, Li C, Liu D, Hu K, et al. Effect of Wuzi Yanzong pills on sertoli cells and blood–testis barrier in heat-stressed rats based on Akt signalling pathway. Andrologia. 2021; 53: e14169.

[10] Hang W, Fan H, Li Y, Xiao Q, Jia L, Song L, et al. Wuzi Yanzong pill attenuates MPTP-induced Parkinson’s Disease via PI3K/Akt signaling pathway. Metabolic Brain Disease. 2022; 37: 1435–1450.

[11] Chen WQ, Wang B, Ding CF, Wan LY, Hu HM, Lv BD, et al. In vivo and in vitro protective effects of the Wuzi Yanzong pill against experimental spermatogenesis disorder by promoting germ cell proliferation and suppressing apoptosis. Journal of Ethnopharmacology. 2021; 280: 114443.

[12] Li Y, Sun M, Hang W, Xiao Q, Fan H, Jia L, et al. Wuzi Yanzong pill relieves CPZ-induced demyelination by improving the microenvironment in the brain. Heliyon. 2022; 8: e12277.

[13] Wang X, Yang C, Ru Y, Xie L, Xiao B, Jin X, et al. An optimal combination of five main monomer components in Wuzi Yanzong pill that prevents neural tube defects and reduces apoptosis and oxidative stress. Journal of Ethnopharmacology. 2023; 313: 116540.

[14] Wang JS, Gong XF, Feng JL, Li HS, Li X, Deng S, et al. Study on the mechanism of Jiawei Shengjiang powder in improving male asthma-induced asthenospermia based on network pharmacology and bioinformatics. Drug Design, Development and Therapy. 2021; 15: 1245–1259.

[15] Cheraghi E, Sajadi SMS, Soleimani Mehranjani M. The effect of quercetin on the quality of sperm parameters in frozen-thawed semen of patients with asthenospermia. Andrologia. 2021; 53: e14167.

[16] Zhang S, Xu L, Yu M, Zhang J. Hypomethylation of the DAZ3 promoter in idiopathic asthenospermia: a screening tool for liquid biopsy. Scientific Reports. 2020; 10: 17996.

[17] Hong G, Zhuang Y, Wang K, Lin H, Zhang R. A case of balanced translocation: 46, XY, t(9;22) (q22;q13) accompanied with oligospermia and asthenospermia. Clinical Laboratory. 2021; 67.

[18] Maghsoumi-Norouzabad L, Zare Javid A, Mansoori A, Dadfar M, Serajian A. Evaluation of the effect of vitamin D supplementation on spermatogram, seminal and serum levels of oxidative stress indices in asthenospermia infertile men: a study protocol for a triple-blind, randomized controlled trial. Nutrition Journal. 2021; 20: 49.

[19] Liu SM, Yao WL, Li CX, Li HQ, Qin GZ. Er-Xian decoction exhibits protective activity in a rat model of asthenospermia through a mechanism associated with DJ-1 protein upregulation. Canadian Journal of Physiology and Pharmacology. 2021; 72.

[20] Wang J, Bao B, Meng F, Deng S, Dai H, Feng J, et al. To study the mechanism of cuscuta chinensis lam. and lycium barbarum L. in the treatment of asthenospermia based on network pharmacology. Journal of Ethnopharmacology. 2021; 270: 113790.

[21] Meng Z, Meng Q, Gao T, Zhou H, Xue J, Li H, et al. Identification of bi-allelic KIF9 loss-of-function variants contributing to asthenospermia and male infertility in two Chinese families. Frontiers in Endocrinology. 2022; 13: 1091107.